Research Article
The Effects of Noncompliance to Prolia (Denosumab) on the Changes in Bone Mineral Density: A Retrospective Review
Table 2
Participant characteristics stratified by time of denosumab injection after one-year follow-up.
| Characteristic | Time of subsequent injection of denosumab | <5 months | 5–7 months | >7 months |
| BMD, mean (SD) | | | | Lumbar spine | 0.909 (0.141) | 0.840 (0.137) | 0.849 (0.102) | Femoral neck | 0.655 (0.080) | 0.638 (0.104) | 0.635 (0.097) | Incident nonvertebral fracture, % () | 0.0% (0) | 2.47% (9) | 3.39% (2) | Incident vertebral fracture, % () | 0.0% (0) | 0.0% (0) | 0.0% (0) |
| Mean duration of treatment from baseline injection in months (SD) | 3.03 (1.18) | 6.05 (0.38) | 9.43 (3.05) |
|
|